Samsung Pharm Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Samsung Pharm Co Ltd

Watchlist Manager

Watchlist

Price: 1 251 KRW -0.24% Market Closed

Market Cap: ₩117.8B

S	Samsung Pharm Co Ltd KRX:001360	KR
	Aena SME SA MAD:AENA	ES
	Alimentation Couche-Tard Inc F:CJA1	CA
	MP Materials Corp NYSE:MP	US

Profitability Summary

Samsung Pharm Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

36%

Sustainable 3Y Average Gross Margin

39%

Declining Gross Margin

46% > 36%

Negative Operating Margin

-38%

Negative 3Y Average Operating Margin

-36%

Declining Operating Margin

-33% > -38%

Negative Net Margin

-321%

Negative 3Y Average Net Margin

-13%

Declining Net Margin

-44% > -321%

Negative Free Cash Flow Margin

-52%

Negative 3Y Average Free Cash Flow Margin

-49%

Free Cash Flow Margin is Increasing

-66% > -52%

Negative ROE

-84%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-16%

ROIC is Increasing

-24% > -9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.